Liposomes for Tumor Targeted Therapy: A Review

Int J Mol Sci. 2023 Jan 31;24(3):2643. doi: 10.3390/ijms24032643.

Abstract

Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug delivery systems, liposomes exhibit prominent properties that include targeted delivery, high biocompatibility, biodegradability, easy functionalization, low toxicity, improvements in the sustained release of the drug it carries and improved therapeutic indices. In the wake of the rapid development of nanotechnology, the studies of liposome composition have become increasingly extensive. The molecular diversity of liposome composition, which includes long-circulating PEGylated liposomes, ligand-functionalized liposomes, stimuli-responsive liposomes, and advanced cell membrane-coated biomimetic nanocarriers, endows their drug delivery with unique physiological functions. This review describes the composition, types and preparation methods of liposomes, and discusses their targeting strategies in cancer therapy.

Keywords: cancer therapy; drug delivery systems; liposomes.

Publication types

  • Review

MeSH terms

  • Drug Carriers / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Liposomes* / therapeutic use
  • Nanotechnology / methods
  • Neoplasms* / drug therapy

Substances

  • Liposomes
  • Drug Carriers